Search > Results
You searched for: EV210279 (EV-TRACK ID)
Showing 1 - 2 of 2
Showing 1 - 2 of 2
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210279 | 1/2 | Homo sapiens | A431 |
(d)(U)C DG |
Libregts SFWM | 2018 | 63% | |
Study summaryFull title
All authors
Libregts SFWM, Arkesteijn GJA, Németh A, Nolte-'t Hoen ENM, Wauben MHM
Journal
J Thromb Haemost
Abstract
Essentials Extracellular vesicles (EVs) in biological fluids are promising biomarkers for disease. F (show more...)
EV-METRIC
63% (93rd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Density gradient Protein markers
EV: EGFR/ CD9/ CD142
non-EV: None Proteomics
no
Show all info
Study aim
Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
A431
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
overnight (16h) at >=100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: rotor type
SW28 or SW32
Pelleting: speed (g)
100000
Density gradient
Type
Continuous
Lowest density fraction
0.4M
Highest density fraction
2.08M
Total gradient volume, incl. sample (mL)
11.6
Sample volume (mL)
0.3
Orientation
Bottom-up
Rotor type
SW 40 Ti
Speed (g)
270000
Duration (min)
960
Fraction volume (mL)
1
Fraction processing
None
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Flow cytometry
Type of Flow cytometry
BD Influx/ Beckman Coulter CytoFLEX LX
Hardware adaptation to ~100nm EV's
BD Influx: Adapted small particle detector
Calibration bead size
0.1 and 0.2
Detected EV-associated proteins
CD9/ EGFR/ CD142
Characterization: Lipid analysis
No
Characterization: Particle analysis
Particle analysis: flow cytometry
Flow cytometer type
BD Influx/ Beckman Coulter Cytoflex LX
Hardware adjustment
BD Influx: adapted small particle detector
Calibration bead size
0.1 and 0.2
EV concentration
Yes
|
||||||||
EV210279 | 2/2 | Homo sapiens | Blood plasma | qEV column | Libregts SFWM | 2018 | 13% | |
Study summaryFull title
All authors
Libregts SFWM, Arkesteijn GJA, Németh A, Nolte-'t Hoen ENM, Wauben MHM
Journal
J Thromb Haemost
Abstract
Essentials Extracellular vesicles (EVs) in biological fluids are promising biomarkers for disease. F (show more...)
EV-METRIC
13% (29th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Commercial method
Protein markers
EV: CD63/ CD9
non-EV: None Proteomics
no
Show all info
Study aim
Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Blood plasma
Separation Method
Commercial kit
qEV column
Characterization: Protein analysis
Protein Concentration Method
Other/ Absorbance spectrometry (280 nm)
Western Blot
Detected EV-associated proteins
CD9/ CD63
Characterization: Lipid analysis
No
Characterization: Particle analysis
Particle analysis: flow cytometry
Flow cytometer type
BD Influx/ Beckman Coulter Cytoflex LX
Hardware adjustment
BD Influx: adapted small particle detector
Calibration bead size
0.1 and 0.2
EV concentration
Yes
|
||||||||
1 - 2 of 2 |
EV-TRACK ID | EV210279 | |
---|---|---|
species | Homo sapiens | |
sample type | Cell culture | Blood plasma |
cell type | A431 | NA |
medium | EV-depleted medium | NA |
condition | Control condition | Control condition |
separation protocol | dUC/ Density gradient | qEV column |
Exp. nr. | 1 | 2 |
EV-METRIC % | 63 | 13 |